Adrian Rawcliffe Wave Life Sciences Ltd. (WVE) insider trading activity

Adrian Rawcliffe is of Wave Life Sciences Ltd.. Currently has a direct ownership of 12,700 shares of WVE, which is worth approximately $87,757. The most recent transaction as insider was on Dec 08, 2025, when has been sold 42,000 shares (Ordinary Shares) at a price of $15.0 per share, resulting in proceeds of $630,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 12.7K

55.93% 3M change

21.19% 12M change

Total Value Held $87,757

Adrian Rawcliffe Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 08 2025	SELL Open market or private sale	$630,000 $15.0 p/Share	42,000 Reduced 76.78%	12,700 Ordinary Shares
Dec 08 2025	BUY Exercise of conversion of derivative security	$250,740 $5.97 p/Share	42,000 Added 43.43%	54,700 Ordinary Shares
Nov 13 2025	SELL Open market or private sale	$109,420 $6.79 p/Share	16,115 Reduced 55.93%	12,700 Ordinary Shares
Aug 11 2025	BUY Grant, award, or other acquisition	-	12,700 Added 30.59%	28,815 Ordinary Shares
Aug 12 2024	BUY Grant, award, or other acquisition	-	16,115 Added 50.0%	16,115 Ordinary Shares

Also insider at

ADAP

Adaptimmune Therapeutics PLC Healthcare

Chief Executive Officer